Abstract
Valproate (VPA), an FDA approved anti-epileptic drug with a half-life of 12–18 h in humans, has been shown to perturb the vacuolar proton pump (vH+-ATPase) function in yeasts by inhibiting myo-inositol phosphate synthase, the first and rate-limiting enzyme in inositol biosynthesis, thereby resulting in inositol depletion. vH+-ATPase transfers protons (H+) across cell membranes, which help maintain pH gradients within cells necessary for various cellular functions including secretion. This proton pump has a membrane (V0) and a soluble cytosolic (V1) domain, with C-subunit associated with V1. In secretory cells such as neurons and insulin-secreting beta cells, vH+-ATPase acidifies vesicles essential for secretion. In this study, we demonstrate that exposure of insulin-secreting Min6 cells to a clinical dose of VPA results in inositol depletion and loss of co-localization of subunit C of vH+-ATPase with insulin-secreting granules. Consequently, a reduction of glucose-stimulated insulin secretion is observed following VPA exposure. These results merit caution and the reassessment of the clinical use of VPA.
References
Barg S, Huang P, Eliasson L, Nelson DJ, Obermuller S, Rorsman P, Thevenod F, Renstrom E (2001) Priming of insulin granules for exocytosis by granular Cl(−) uptake and acidification. J Cell Sci 114(11):2145–2154
Berridge MJ, Irvine RF (1984) Inositol trisphosphate, a novel second messenger in cellular signaltransduction. Nature 312(5992):315–321
Berridge MJ, Irvine RF (1989) Inositol phosphates and cell signalling. Nature 341(6239):197–205. https://doi.org/10.1038/341197a0
Bertelsen F, Moller A, Folloni D, Drasbek KR, Scheel-Kruger J, Landau AM (2007) Increased GABAA receptor binding in amygdala after prenatal administration of valproic acid to rats. Acta Neuropsychiatr 29(5):309–314. https://doi.org/10.1017/neu.2016.59
Bodzeta A, Kahms M, Klingauf J (2017) The presynaptic v-ATPase reversibly disassembles and thereby modulates exocytosis but is not part of the fusion machinery. Cell Rep 20(6):1348–1359. https://doi.org/10.1016/j.celrep.2017.07.040
Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254
Brunner Y, Coute Y, Iezzi M, Foti M, Fukuda M, Hochstrasser DF, Wollheim CB, Sanchez JC (2007) Proteomics analysis of insulin secretory granules. Mol Cell Proteom 6(6):1007–1017. https://doi.org/10.1074/mcp.M600443-MCP200
Deranieh RM, He Q, Caruso JA, Greenberg ML (2013) Phosphorylation regulates myo-inositol-3-phosphate synthase: a novel regulatory mechanism of inositol biosynthesis. J Biol Chem 288(37):26822–26833. https://doi.org/10.1074/jbc.M113.479121
Deranieh RM, Shi Y, Tarsio M, Chen Y, McCaffery JM, Kane PM, Greenberg ML (2015) Perturbation of the vacuolar ATPase: a novel consequence of inositol depletion. J Biol Chem 290(46):27460–27472. https://doi.org/10.1074/jbc.M115.683706
Di Giovanni J, Boudkkazi S, Mochida S, Bialowas A, Samari N, Leveque C, Youssouf F, Brechet A, Iborra C, Maulet Y, Moutot N, Debanne D, Seagar M, El Far O (2010) V-ATPase membrane sector associates with synaptobrevin to modulate neurotransmitter release. Neuron 67(2):268–279. https://doi.org/10.1016/j.neuron.2010.06.024
Dozawa M, Kono H, Sato Y, Ito Y, Tanaka H, Ohshima T (2014) Valproic acid, a histone deacetylase inhibitor, regulates cell proliferation in the adult zebrafish optic tectum. Dev Dyn 243(11):1401–1415. https://doi.org/10.1002/dvdy.24173
El Far O, Seagar M (2011) A role for V-ATPase subunits in synaptic vesicle fusion? J Neurochem 117(4):603–612. https://doi.org/10.1111/j.1471-4159.2011.07234.x
Forgac M (2007) Vacuolar ATPases: rotary proton pumps in physiology and pathophysiology. Nat Rev Mol Cell Biol 8(11):917. https://doi.org/10.1038/nrm2272
Ganai SA, Kalladi SM, Mahadevan V (2015) HDAC inhibition through valproic acid modulates the methylation profiles in human embryonic kidney cells. J Biomol Struct Dyn 33(6):1185–1197. https://doi.org/10.1080/07391102.2014.938247
Iwata M, Imamura H, Stambouli E, Ikeda C, Tamakoshi M, Nagata K, Makyio H, Hankamer B, Barber J, Yoshida M, Yokoyama K, Iwata S (2004) Crystal structure of a central stalk subunit C and reversible association/dissociation of vacuole-type ATPase. Proc Natl Acad Sci USA 101(1):59–64
Kane PM (2006) The where, when, and how of organelle acidification by the yeast vacuolar H(+)-ATPase. Microbiol Mol Biol Rev 70(1):177–191. https://doi.org/10.1128/MMBR.70.1.177-191.2006
Kumamaru E, Egashira Y, Takenaka R, Takamori S (2014) Valproic acid selectively suppresses the formation of inhibitory synapses in cultured cortical neurons. Neurosci Lett 569:142–147. https://doi.org/10.1016/j.neulet.2014.03
Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227(5259):680. https://doi.org/10.1038/227680a0
Liu Y, Bankaitis VA (2010) Phosphoinositide phosphatases in cell biology and disease. Prog Lipid Res 49(3):201–217. https://doi.org/10.1016/j.plipres.2009.12.001
Louagie E, Taylor NA, Flamez D, Roebroek AJ, Bright NA, Meulemans S, Quintens R, Herrera PL, Schuit F, Van de Ven WJ, Creemers JW (2008) Role of furin in granular acidification in the endocrine pancreas: identification of the V-ATPase subunit Ac45 as a candidate substrate. Proc Natl Acad Sci USA 105(34):12319–12324. https://doi.org/10.1073/pnas.0800340105
Lubrich B, Patishi Y, Kofman O, Agam G, Berger M, Belmaker RH, Van Calker D (1997) Lithium-induced inositol depletion in rat brain after chronic treatment is restricted to the hypothalamus. Mol Psychiatry 2(5):407–412
Maslanski JA, Busa WB (1990) A sensitive and specific mass assay for myo-inositol and inositol phosphates. In: Rf I (ed) Methods in inositide research. Raven Press, Ltd, New York, pp 113-126
Morel N (2003) Neurotransmitter release: the dark side of the vacuolar-H+ATPase. Biol Cell 95(7):453–457
Morel N, Poëa-Guyon S (2015) The membrane domain of vacuolar H+ATPase: a crucial player in neurotransmitter exocytotic release. Cell Mol Life Sci 72(13):2561–2573. https://doi.org/10.1007/s00018-015-1886-2
Naik AR, Kulkarni SP, Lewis KT, Taatjes DJ, Jena BP (2016) Functional reconstitution of the insulin-secreting porosome complex in live cells. Endocrinology 157(1):54–60. https://doi.org/10.1210/en.2015-1653
Nalivaeva NN, Belyaev ND, Turner AJ (2009) Sodium valproate: an old drug with new roles. Trends Pharmacol Sci 30(10):509–514. https://doi.org/10.1016/j.tips.2009.07.002
Poea-Guyon S, Ammar MR, Erard M, Amar M, Moreau MW, Fossier P, Gleize V, Vitale N, Morel N (2013) The V-ATPase membrane domain is a sensor of granular pH that controls the exocytotic machinery. J Cell Biol 203(2):283–298. https://doi.org/10.1083/jcb.201303104
Sautin YY, Lu M, Gaugler A, Zhang L, Gluck SL (2005) Phosphatidylinositol 3-kinase-mediated effects of glucose on vacuolar H(+)-ATPase assembly, translocation, and acidification of intracellular compartments in renal epithelial cells. Mol Cell Biol 25(2):575–589. https://doi.org/10.1128/MCB.25.2.575-589.2005
Scott DF (1993) The history of epileptic therapy: an account of how medication was developed. Parthenon Publishing Group, New York, p 131
Shaltiel G, Shamir A, Shapiro J, Ding D, Dalton E, Bialer M, Harwood AJ, Belmaker RH, Greenberg ML, Agam G (2004) Valproate decreases inositol biosynthesis. Biol Psychiatry 56(11):868–874. https://doi.org/10.1016/j.biopsych.2004.08.027
Sun-Wada G-H, Toyomura T, Murata Y, Yamamoto A, Futai M, Wada Y (2006) The a3 isoform of V-ATPase regulates insulin secretion from pancreatic β-cells. J Cell Sci 119(21):4531
Teo R, King J, Dalton E, Ryves J, Williams RS, Harwood AJ (2009) PtdIns(3,4,5)P(3) and inositol depletion as a cellular target of mood stabilizers. Biochem Soc Trans 37(5):1110–1114. https://doi.org/10.1042/bst0371110
Tompkins LS, Nullmeyer KD, Murphy SM, Weber CS, Lynch RM (2002) Regulation of secretory granule pH in insulin-secreting cells. Am J Physiol Cell Physiol 283(2):C429–C437. https://doi.org/10.1152/ajpcell.01066.2000
Wang D, Epstein D, Khlaf O, Srinivasan S, Williamson WR, Fayyazuddin A, Quiocho FA, Hiesinger PR (2014) Ca2+-Calmodulin regulates SNARE assembly and spontaneous neurotransmitter release via v-ATPase subunit V0a1. J Cell Biol 205(1):21–31. https://doi.org/10.1083/jcb.201312109
Williams RS, Cheng L, Mudge AW, Harwood AJ (2002) A common mechanism of action for three mood-stabilizing drugs. Nature 417(6886):292–295. https://doi.org/10.1038/417292a
Yu W, Ye C, Greenberg ML (2016) Inositol hexakisphosphate kinase 1 (IP6K1) regulates inositol synthesis in mammalian cells. J Biol Chem 291(20):10437–10444. https://doi.org/10.1074/jbc.M116.714816
Acknowledgements
Work presented in this article was supported in part by the National Science Foundation Grant CBET1066661 (BPJ); the WSU Interdisciplinary Biomedical Systems Fellowship (ARN); and R01 GM125082-05A1 from the National Institutes of Health (to M.L.G.). All authors critically analyzed results and proof read the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have nothing to disclose.
Rights and permissions
About this article
Cite this article
Yedulla, N.R., Naik, A.R., Kokotovich, K.M. et al. Valproate inhibits glucose-stimulated insulin secretion in beta cells. Histochem Cell Biol 150, 395–401 (2018). https://doi.org/10.1007/s00418-018-1713-6
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00418-018-1713-6